NDC 0338-9667 – Doxil
Doxorubicin Hydrochloride 2 mg/mL · Injection, Suspension, Liposomal · Intravenous
Product NDC0338-9667
Product details
- Brand name
- Doxil
- Generic name
- Doxorubicin hydrochloride
- Labeler
- Baxter Healthcare Corporation
- Dosage form
- Injection, Suspension, Liposomal
- Route
- Intravenous
- Marketing category
- NDA · NDA050718
- Marketed since
- August 26, 2024
- Listing expires
- December 31, 2027
- Pharmacologic class
- Anthracycline Topoisomerase Inhibitor
Active ingredients
- Doxorubicin Hydrochloride 2 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0338-9667-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0338-9667-01) / 10 mL in 1 VIAL, SINGLE-DOSE | Aug 26, 2024 |
Other Doxil products
- 0338-0063 Doxorubicin Hydrochloride 2 mg/mL · Injection, Suspension, Liposomal · Baxter Healthcare Company
- 0338-0067 Doxorubicin Hydrochloride 2 mg/mL · Injection, Suspension, Liposomal · Baxter Healthcare Company
- 0338-9665 Doxorubicin Hydrochloride 2 mg/mL · Injection, Suspension, Liposomal · Baxter Healthcare Corporation